Search clinical trials for: Carmellose
Total 2 results
-
C.O.C. Farmaceutici S.r.l.CompletedDry Eye | Dry Eye Disease | Kerato Conjunctivitis SiccaItaly
-
NicOxTheradis pharma; Iris PharmaWithdrawnAdenoviral ConjunctivitisSpain
Sponsors and Collaborators
- Genuv Inc.
- Sahar Salehi
- Kuwait University
- Liming Cheng
- Hopeful Aging
- Biorobotic Institute Scuola Superiore sant'Anna Pisa
- Van Boven, Robert W., M.D.
- FutureGen Biopharmaceutical (Beijing) Co., Ltd
- Hoersholm Hospital
- Royal Hobart Hospital Research Foundation (funding source)
- Klinikum Bad Woerishofen
- The People's Hospital of Guangxi Zhang Autonomous Region
- Egyptian Russian University
- Jia Liu
- Pancreatic Cancer UK
- Friedrich Miescher Institute for Biomedical Research (FMI)
- Only For Children Pharmaceuticals
- Kerstyn C. Zalesin, M.D.
- Xiao-Ming Mao
- Marcus Vinícius Guimarães de Lacerda
- View Full List
Medical Conditions
- EHMT1
- Urinary Tract Carcinoma
- Stage II Vulvar Cancer
- Raynaud Secondary to Other Autoimmune Disease
- Enlarged Uterus
- Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia
- Caffeine Dosage
- High Perinatal Mortality
- Global Health
- Role of Vitamin D in IVF for Better Outcome
- Stereotype-threat
- Gait Variability; Elders; Fall; Re-education
- Smith-Lemli-Opitz Syndrome
- Autologous Haematopoietic Stem Cell Transplant
- Pancytopenia Due to Chemotherapy
- Airway Obstruction
- Secondary Hypertension to Endocrine Disorders
- Using Imagery to Maintain Muscle Mass Gains in the Quadriceps
- Advanced Gastric Cancer With Serosal Invasion
- Pulmonary Invasive Aspergillosis
- View Full List
Drug Interventions
- CAZ/AVI plus Aztreonam
- Ustekinumab
- APD334
- Ibudilast
- Nystatin
- ACP-204
- Clostridium Botulinum Toxin Type A (Nabota, DWP 450) 50 U
- MC-1101
- Iohexol Inj 300 MG/ML
- Omalizumab Injection
- Naltrexone and bupropion SR
- IBI318
- P276-00
- Androgen-deprivation Therapy (ADT)
- High-dose loop diuretics
- Vehicle Foam with UVA and UVB and visible light irradiation
- RDEA3170 12 mg
- Olopatadine hydrochloride ophthalmic solution 0.7%)
- Jatenzo
- LX4211 800 mg
- View Full List
CROs by country
- Contract Research Organizations in Albania
- Contract Research Organizations in Denmark
- Contract Research Organizations in Ethiopia
- Contract Research Organizations in Germany
- Contract Research Organizations in Greece
- Contract Research Organizations in Kenya
- Contract Research Organizations in Lithuania
- Contract Research Organizations in Mali
- Contract Research Organizations in Panama
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Poland
- Contract Research Organizations in Togo
- Contract Research Organizations in Ukraine
- CRO list by country